ELISA News and Research

RSS

Researchers use ultrasound technique to accurately localize cardiac arrhythmias

Cardiac arrhythmias are a major cause of morbidity and mortality worldwide. Currently, the 12-lead electrocardiogram is the noninvasive clinical gold standard used to diagnose and localize these conditions, but it has limited accuracy, cannot provide an anatomical tool to visually localize the source of the arrhythmia, and depending on which clinician is looking at the signals, there might be some interpretation variability.

25 Mar 2020

Simple blood test could be used by GPs to aid in earlier brain tumor diagnosis

A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.

24 Feb 2020

Rhizosphere microbiome can systemically shape and control root exudation

Roots are plant organs, that typically absorb water and minerals from soil. It is lesser known that roots also secrete metabolites, so-called root exudates, which impact the properties of soil directly around the root.

9 Feb 2020

Mycoplasma in Cell Culture: Fighting Back with Rapid Detection Kits

In this interview, discussing the effects of mycoplasma contamination on cell cultures and the development of rapid detection kits that provide answers in just thirty minutes.

From Gold Biotechnology, Inc. 24 Jan 2020

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

The growing trend of implementing immunotherapy into oncology has resulted in various new therapeutic cancer treatments utilizing antibodies.

From Sartorius 3 Dec 2019

Applying a Proteomics-based Approach to the Clinic

Matthias Mann explains why applying proteomics-based technologies such as timsTOF could accelerate the diagnosis and prediction of human disease.

From Bruker Life Sciences Mass Spectrometry 20 Nov 2019

Breast cancer could soon be detected early using a blood test

Researchers have found that breast cancer may be successfully detected up to five years before any symptoms appear using a blood test. The results of this land mark study which could mean diagnosis of breast cancer early and treating it more effectively, were presented at the 2019 NCRI Cancer Conference Sunday (3rd November 2019).

4 Nov 2019

New microfluidic test can detect Lyme disease within 15 minutes

Some 300,000 people in the U.S. are diagnosed with Lyme disease every year. Caused by Borrelia burgdorferi and transmitted by the bite of infected Ixodes ticks, the disease if left untreated can cause serious neurologic, cardiac, and/or rheumatologic complications.

11 Oct 2019

Parkinson's disease also connected with the immune system, confirms new study

The behaviour of immune cells in the blood is so different in patients with Parkinson's disease that it advocates for a new type of supplementary medicine, which can regulate the immune system and thus inhibit the deterioration of the brain.

3 Oct 2019

Ability of people with autism to infer mental states from faces may have been underestimated

The ability of people with autism to read what someone is feeling or thinking by looking at their eyes and face may have been underestimated, according to research conducted by a developmental psychology expert from London's Kingston University.

17 Sep 2019

Vapers seek relief from nicotine addiction in — wait for it — cigarettes

Lucas McClain started smoking cigarettes in high school but switched to vaping after he heard e-cigarettes were a safer alternative.

13 Sep 2019

Accelerating Nanobody Production using Polyclonal Anti-VHH Antibodies

In this interview, Dr. Dave Fancy, CEO of Jackson ImmunoResearch explains how anti-VHH antibodies can be used to produce nanobodies and VHH libraries.

From Jackson ImmunoResearch Laboratories, Inc. 12 Sep 2019

Gyros Protein Technologies launches Gyrolab p24 Kit for scientists in cell and gene therapy market

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® p24 Kit, for lentivirus titer determination in lentivirus vector manufacturing.

From Gyros Protein Technologies AB 11 Sep 2019

FDA clears existing tests with new indications to aid in the diagnosis of Lyme disease

Today, the U.S. Food and Drug Administration cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease.

30 Jul 2019

Randox unveils innovative test for risk assessment of cardiovascular disease

Global diagnostics company Randox Laboratories has unveiled an innovative new test for the risk assessment of cardiovascular disease at this year's AACC Clinical Lab Expo in Anaheim, California.

26 Jul 2019

Researchers analyze link between videogame addiction and school inadaptation

A team of researchers from the departments of Medicine and Education Sciences of the CEU Cardenal Herrera University in Castellón (Spain) has analyzed the relation between the addiction to videogames and school inadaptation in a group of teenagers in the province.

12 Jul 2019

Quanterix announces agreement to acquire UmanDiagnostics, world’s leading neurofilament light (Nf-l) antibody supplier

Quanterix announce agreement to acquire privately held UmanDiagnostics AB for $22.5 million.

From Quanterix 26 Jun 2019

ELISA test performed in 3D-printed pipette tips simplifies process, reduces cost

Scientists have taken a common, yet laborious lab test and redesigned it to be performed in small 3D printed pipette tips used to measure and transfer fluids in the laboratory.

26 Jun 2019

TEST-1 Using SPR to Confront the Antibody Reproducibility Crisis

It is important to validate parameters of purchased antibodies with SPR to ensure they are high-quality and also useful for your application,

From Nicoya Lifesciences 19 Jun 2019

New tool will help implement more precise treatments for patients with cardiogenic shock

A joint research effort by the Hospital and the Instituto de Investigación Germans Trias i Pujol is characterizing and studying a new cohort of cardiogenic shock patients to predict the risk of having this heart attack-derived complication which, while infrequent, sometimes presents a fatal outcome.

17 Jun 2019